(Q33544391)

27 July 2017

1 reference

title

The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system? (English)

1 reference

27 July 2017

1 reference

Heisel A

1

1 reference

27 July 2017

Jung J

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

American Journal of Cardiology

27 July 2017

published in

1 reference

27 July 2017

volume

83

1 reference

27 July 2017

issue

5B

1 reference

27 July 2017

page(s)

218D-226D

1 reference

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Impact of atrial fibrillation on mortality, stroke, and medical costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Atrial fibrillation: maintenance of sinus rhythm versus rate control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

An 8 1/2-year clinical experience with surgery for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Initial clinical experience with an implantable human atrial defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Relation between transcardiac and transthoracic current during defibrillation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal cardioversion of atrial fibrillation in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Safety of atrial defibrillation shocks synchronized to narrow and wide QRS complexes during atrial pacing protocols simulating atrial fibrillation in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Safety of transvenous atrial defibrillation: studies in the canine sterile pericarditis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal cardioversion of atrial fibrillation: marked reduction in defibrillation threshold with dual current pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low-energy transvenous cardioversion defibrillation of atrial tachyarrhythmias in the canine: an assessment of electrode configurations and monophasic pulse sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Intracavitary electrode catheter cardioversion of atrial tachyarrhythmias in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low energy conversion of atrial fibrillation in the sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Efficacy and Tolerability in Fully Conscious Patients of Transvenous Low-Energy Internal Atrial Cardioversion for Atrial Fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biatrial biphasic shocks in patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low-energy intracardiac shocks during atrial fibrillation: effects on cardiac rhythm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Changes in intracardiac atrial cardioversion threshold at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal cardioversion of chronic atrial fibrillation in patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Effect of electrode length on atrial defibrillation thresholds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

An implantable atrial defibrillator. An impossible dream?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Implantable atrial defibrillators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Implantable atrial defibrillator: quo vadis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Atrial defibrillation: can modifications in current implantable cardioverter-defibrillators achieve this?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

The effect of biphasic waveform tilt in transvenous atrial defibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Effect of parenteral d-sotalol on transvenous atrial defibrillation threshold in a canine model of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Effect of atrial fibrillation on atrial refractoriness in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Immediate reinitiation of atrial fibrillation following internal atrial defibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Effects of atrial defibrillation shocks on the ventricles in isolated sheep hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Ventricular fibrillation resulting from synchronized internal atrial defibrillation in a patient with ventricular preexcitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Impact of pulse characteristics on atrial defibrillation energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Atrioverter: an implantable device for the treatment of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

7 January 2021

[Atrial defibrillator]

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Electrocardiographically Documented Unnecessary, Spontaneous Shocks in 241 Patients With Implantable Cardioverter Defibrillators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Preliminary clinical experience with the first dual chamber pacemaker defibrillator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Interventional therapeutic procedures in patients with a preexisting dual site right atrial pacing system for refractory atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Complications of pacemaker-defibrillator devices: diagnosis and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

The automatic implantable defibrillator: it can be done, but should it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

Efficacy of a new balloon catheter for internal cardioversion of chronic atrial fibrillation without anaesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Pacing strategies to prevent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901032-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(98)01032-7

1 reference

27 July 2017

1 reference